Fukuoka, Japan

Shinji Takeda

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Pharma Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Takeda. Retrieved from https://idiyas.com/inventor/shinji-takeda-a9f9mt7r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinji Takeda

Introduction

Shinji Takeda is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on hydroxamic acid derivatives. His research has the potential to impact various therapeutic applications.

Latest Patents

Shinji Takeda holds a patent for "Hydroxamic acid derivatives and medicinal utilization thereof." This patent showcases his expertise in developing compounds that may have important medicinal uses. He has successfully secured 1 patent in this area, reflecting his commitment to advancing medical science.

Career Highlights

Currently, Shinji Takeda is associated with Mitsubishi Pharma Corporation, where he continues to explore new avenues in pharmaceutical research. His role at the company allows him to collaborate with other talented professionals in the field, enhancing the potential for groundbreaking discoveries.

Collaborations

Shinji has worked alongside notable colleagues such as Naoki Sugiyama and Kazuhiro Maeda. Their combined efforts contribute to a dynamic research environment that fosters innovation and creativity.

Conclusion

Shinji Takeda's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing new medicinal solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…